174 related articles for article (PubMed ID: 21584737)
1. Cannabinoid WIN 55,212-2 inhibits TRPV1 in trigeminal ganglion neurons via PKA and PKC pathways.
Wang W; Cao X; Liu C; Liu L
Neurol Sci; 2012 Feb; 33(1):79-85. PubMed ID: 21584737
[TBL] [Abstract][Full Text] [Related]
2. Cannabinoid receptor-independent actions of the aminoalkylindole WIN 55,212-2 on trigeminal sensory neurons.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 May; 142(2):257-66. PubMed ID: 15155534
[TBL] [Abstract][Full Text] [Related]
3. The cannabinoid WIN 55,212-2 inhibits transient receptor potential vanilloid 1 (TRPV1) and evokes peripheral antihyperalgesia via calcineurin.
Patwardhan AM; Jeske NA; Price TJ; Gamper N; Akopian AN; Hargreaves KM
Proc Natl Acad Sci U S A; 2006 Jul; 103(30):11393-8. PubMed ID: 16849427
[TBL] [Abstract][Full Text] [Related]
4. Potentiation by WIN 55,212-2 of GABA-activated currents in rat trigeminal ganglion neurones.
Li ZW; Zhang J; Ouyang CH; Li CY; Zhao FB; Liu YW; Ai YX; Hu WP
Br J Pharmacol; 2009 Dec; 158(8):1904-10. PubMed ID: 19917064
[TBL] [Abstract][Full Text] [Related]
5. Cannabinoid WIN 55,212-2 regulates TRPV1 phosphorylation in sensory neurons.
Jeske NA; Patwardhan AM; Gamper N; Price TJ; Akopian AN; Hargreaves KM
J Biol Chem; 2006 Oct; 281(43):32879-90. PubMed ID: 16954222
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of interleukin-1β-induced endothelial tissue factor expression by the synthetic cannabinoid WIN 55,212-2.
Scholl A; Ivanov I; Hinz B
Oncotarget; 2016 Sep; 7(38):61438-61457. PubMed ID: 27556861
[TBL] [Abstract][Full Text] [Related]
7. Neuronal nitric oxide synthase is involved in CB/TRPV1 signalling: Focus on control of hippocampal hyperexcitability.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2017 Dec; 138():18-25. PubMed ID: 29035821
[TBL] [Abstract][Full Text] [Related]
8. Cannabinoid receptor 1 suppresses transient receptor potential vanilloid 1-induced inflammatory responses to corneal injury.
Yang Y; Yang H; Wang Z; Varadaraj K; Kumari SS; Mergler S; Okada Y; Saika S; Kingsley PJ; Marnett LJ; Reinach PS
Cell Signal; 2013 Feb; 25(2):501-11. PubMed ID: 23142606
[TBL] [Abstract][Full Text] [Related]
9. Suppression of outward K⁺ currents by WIN55212-2 in rat retinal ganglion cells is independent of CB1/CB2 receptors.
Zhang CQ; Wu HJ; Wang SY; Yin S; Lu XJ; Miao Y; Wang XH; Yang XL; Wang Z
Neuroscience; 2013 Dec; 253():183-93. PubMed ID: 24013008
[TBL] [Abstract][Full Text] [Related]
10. Signaling pathways from cannabinoid receptor-1 activation to inhibition of N-methyl-D-aspartic acid mediated calcium influx and neurotoxicity in dorsal root ganglion neurons.
Liu Q; Bhat M; Bowen WD; Cheng J
J Pharmacol Exp Ther; 2009 Dec; 331(3):1062-70. PubMed ID: 19752241
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor receptor transactivation by the cannabinoid receptor (CB1) and transient receptor potential vanilloid 1 (TRPV1) induces differential responses in corneal epithelial cells.
Yang H; Wang Z; Capó-Aponte JE; Zhang F; Pan Z; Reinach PS
Exp Eye Res; 2010 Sep; 91(3):462-71. PubMed ID: 20619260
[TBL] [Abstract][Full Text] [Related]
12. Involvement of TRPV1 channels in the activity of the cannabinoid WIN 55,212-2 in an acute rat model of temporal lobe epilepsy.
Carletti F; Gambino G; Rizzo V; Ferraro G; Sardo P
Epilepsy Res; 2016 May; 122():56-65. PubMed ID: 26970948
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of spontaneous neurotransmission in the nucleus of solitary tract of the rat by the cannabinoid agonist WIN 55212-2 is not via CB1 or CB2 receptors.
Accorsi-Mendonça D; Almado CE; Dagostin AL; Machado BH; Leão RM
Brain Res; 2008 Mar; 1200():1-9. PubMed ID: 18308297
[TBL] [Abstract][Full Text] [Related]
14. Modulation of trigeminal sensory neuron activity by the dual cannabinoid-vanilloid agonists anandamide, N-arachidonoyl-dopamine and arachidonyl-2-chloroethylamide.
Price TJ; Patwardhan A; Akopian AN; Hargreaves KM; Flores CM
Br J Pharmacol; 2004 Apr; 141(7):1118-30. PubMed ID: 15006899
[TBL] [Abstract][Full Text] [Related]
15. The cannabinoid WIN 55,212-2-mediated protection of dentate gyrus granule cells is driven by CB1 receptors and modulated by TRPA1 and Cav 2.2 channels.
Koch M; Kreutz S; Böttger C; Grabiec U; Ghadban C; Korf HW; Dehghani F
Hippocampus; 2011 May; 21(5):554-64. PubMed ID: 20135626
[TBL] [Abstract][Full Text] [Related]
16. Effects of WIN55,212-2 on voltage-gated sodium channels in trigeminal ganglion neurons of rats.
Fu H; Xiao JM; Cao XH; Ming ZY; Liu LJ
Neurol Res; 2008 Feb; 30(1):85-91. PubMed ID: 17767805
[TBL] [Abstract][Full Text] [Related]
17. Cannabinoid and kappa opioid receptors reduce potassium K current via activation of G(s) proteins in cultured hippocampal neurons.
Hampson RE; Mu J; Deadwyler SA
J Neurophysiol; 2000 Nov; 84(5):2356-64. PubMed ID: 11067978
[TBL] [Abstract][Full Text] [Related]
18. Diabetic thermal hyperalgesia: role of TRPV1 and CB1 receptors of periaqueductal gray.
Mohammadi-Farani A; Sahebgharani M; Sepehrizadeh Z; Jaberi E; Ghazi-Khansari M
Brain Res; 2010 Apr; 1328():49-56. PubMed ID: 20211611
[TBL] [Abstract][Full Text] [Related]
19. Effects of cannabinoid and vanilloid receptor agonists and their interaction on learning and memory in rats.
Shiri M; Komaki A; Oryan S; Taheri M; Komaki H; Etaee F
Can J Physiol Pharmacol; 2017 Apr; 95(4):382-387. PubMed ID: 28112976
[TBL] [Abstract][Full Text] [Related]
20. TRPA1-mediated responses in trigeminal sensory neurons: interaction between TRPA1 and TRPV1.
Salas MM; Hargreaves KM; Akopian AN
Eur J Neurosci; 2009 Apr; 29(8):1568-78. PubMed ID: 19419422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
